España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Paradigm Capital
Lifeist Sells Non-Core Swedish Subsidiary Findify For $4.45M To Maropost
Bitcoin Miner Genesis Digital Assets Raises $431M For Expansion
Potash Corp. Shares Downgraded To Sell Amid 'Rally On Shaky Ground'
Bitcoin Miner Genesis Digital Assets Raises $431M For Expansion
Potash Corp. Shares Downgraded To Sell Amid 'Rally On Shaky Ground'
UPDATE: Paradigm Capital Downgrades BlackBerry Following Disappointing Q2 FY14 Results
UPDATE: Paradigm Capital Upgrades OpenText on Valuation, Multiple Catalysts
UPDATE: Paradigm Capital Downgrades BlackBerry Following Disappointing Q2 FY14 Results
UPDATE: Paradigm Capital Upgrades OpenText on Valuation, Multiple Catalysts
US Stock Futures Up Ahead Of Consumer Credit Data
UPDATE: Paradigm Capital Downgrades OpenText on Possible Turbulence Ahead
Read More...
Paradigm Capital Recent News
UPDATE: Paradigm Capital Upgrades BlackBerry to Speculative Buy on Q4 Results
UPDATE: Paradigm Capital Raises PT on Valeant Pharmaceuticals on Company Acquisition
UPDATE: Paradigm Capital Lowers PT on IMRIS on Additions to Balance Sheet
UPDATE: Paradigm Capital Downgrades Nordion to Hold on Diminished Outlook
UPDATE: Paradigm Capital Upgrades Celestica to Buy, Raises PT
UPDATE: Paradigm Capital Downgrades Research In Motion to Hold on Service Model Changes
UPDATE: Paradigm Capital Reiterates Buy Rating, Raises PT on Celestica
UPDATE: Paradigm Capital Lowers PT to $67 on Valeant Pharmaceuticals on Raising Interest Cost
UPDATE: Paradigm Capital Downgrades Thompson Creek Metals Company to Hold
UPDATE: Paradigm Capital Reiterates Potash Corporation of Saskatchewan at Buy with $74 PT
UPDATE: Paradigm Capital Upgrades Nordion to Buy Post Sell-Off
UPDATE: Paradigm Capital Downgrades Nordion to Hold, Reiterates $11 PT
UPDATE: Paradigm Capital Downgrades CGI Group to Hold, Raises PT
UPDATE: Paradigm Capital Initiates Coverage on Merus Labs